{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:41:43Z","timestamp":1787499703055,"version":"build-2736575974"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:00Z","timestamp":1620950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Lessons Learned<\/jats:title>\n                    <jats:p>Staphylococcus aureus infection in cutaneous T-cell lymphoma (CTCL) is thought to contribute to disease progression; thus, adjunctive treatment with antibiotics warrants further investigation. This trial of antibiotic therapy followed by imiquimod in early stage CTCL was not completed because of difficulties with patient accrual.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cutaneous T-cell lymphoma (CTCL), a form of non-Hodgkin lymphoma, is a heterogeneous group of malignancies of mature memory T lymphocytes. It has an annual age-adjusted incidence of 7.5 per million persons in the U.S. population [1]. The etiology of CTCL is unknown, but epidemiological studies have reported potential associations with environmental and occupational factors, including Agent Orange exposure in Vietnam Veterans [2]. Both topical and systemic therapies have been identified as effective in CTCL; the choice of treatment is dependent on disease stage, with the overall goal of improving symptoms given the chronic and recurrent nature of the disease. Several studies have suggested that CTCL is exacerbated by the presence of Staphylococcus aureus in the skin and can be ameliorated by treatment with antibiotics [3].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Our study was designed to assess the effects of antibiotics and imiquimod on early stage CTCL. Patients between the ages of 30\u201389\u2009years with stage I and II CTCL were eligible for enrollment. They could not be receiving concurrent therapy, and the study design included a 14-day washout period after discontinuation of CTCL therapy. The washout period was followed by doxycycline 100 mg p.o. b.i.d. for 14\u2009days and then two packets (250 mg per packet) of imiquimod 5% cream topically to the most clinically active lesions 3\u2009days a week (Monday, Wednesday, and Friday) for 28\u2009days. Skin lesions were measured using the modified Severity Weighted Assessment Tool (mSWAT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our study enrolled only two patients with early stage CTCL because of difficulty locating patients with active CTCL able to discontinue all therapy. The two enrolled patients completed all therapy. One patient had a complete response after imiquimod, whereas the other patient had stable disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Antibiotics and imiquimod have reported activity as single agents in CTCL; we did not enroll enough patients to assess value in the sequence of antibiotic therapy followed by imiquimod.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/onco.13785","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T18:56:17Z","timestamp":1618426577000},"page":"727-e1488","source":"Crossref","is-referenced-by-count":6,"title":["Antibiotics and Imiquimod for\n                    <scp>Cutaneous T-Cell Lymphoma<\/scp>\n                    in Veterans: A Patient Population with Agent Orange Exposure"],"prefix":"10.1093","volume":"26","author":[{"given":"Christina A.","family":"Del Guzzo","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsenije","family":"Kojadinovic","sequence":"additional","affiliation":[{"name":"Hematology and Oncology, James J. Peters Veterans Affairs Medical Center, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi R.","family":"Vinnakota","sequence":"additional","affiliation":[{"name":"Department of Dermatology, James J. Peters Veterans Affairs Medical Center, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa J.","family":"Geskin","sequence":"additional","affiliation":[{"name":"Departments of Dermatology, Columbia University Medical Center, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Newman","sequence":"additional","affiliation":[{"name":"Department of Dermatology, James J. Peters Veterans Affairs Medical Center, Bronx, New York, USA"},{"name":"Departments of Dermatology, Columbia University Medical Center, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Langhoff","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Mt. Sinai School of Medicine, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeun-Hee A.","family":"Park","sequence":"additional","affiliation":[{"name":"Hematology and Oncology, James J. Peters Veterans Affairs Medical Center, Bronx, New York, USA"},{"name":"Department of Hematology and Oncology, Columbia University Medical Center, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Bates","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Columbia University Medical Center, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali N.","family":"Dana","sequence":"additional","affiliation":[{"name":"Department of Dermatology, James J. Peters Veterans Affairs Medical Center, Bronx, New York, USA"},{"name":"Bellaire Dermatology, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,5,14]]},"reference":[{"key":"2022012102313899400_onco13785-bib-0001","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamadermatol.2013.5526","article-title":"Changing incidence trends of cutaneous T-cell lymphoma","volume":"149","author":"Korgavkar","year":"2013","journal-title":"JAMA Dermatol"},{"key":"2022012102313899400_onco13785-bib-0002","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000018423","article-title":"Mycosis fungoides: Review of epidemiological observations","volume":"201","author":"Su\u00e1rez-Varela","year":"2000","journal-title":"Dermatology"},{"key":"2022012102313899400_onco13785-bib-0003","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/blood.2018888107","article-title":"Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma","volume":"134","author":"Lindahl","year":"2019","journal-title":"Blood"},{"key":"2022012102313899400_onco13785-bib-0004","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1182\/blood-2015-08-662353","article-title":"Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma","volume":"127","author":"Willerslev-Olsen","year":"2016","journal-title":"Blood"},{"key":"2022012102313899400_onco13785-bib-0005","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1751561","article-title":"Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma","volume":"9","author":"Bl\u00fcmel","year":"2020","journal-title":"Oncoimmunology"},{"key":"2022012102313899400_onco13785-bib-0006","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/978-3-319-29785-9_41","volume-title":"Clinical and Basic Immunodermatology","author":"Stephen","year":"2017","edition":"Second Ed."},{"key":"2022012102313899400_onco13785-bib-0007","doi-asserted-by":"crossref","first-page":"10","DOI":"10.21037\/cco.2019.01.02","article-title":"Systemic therapy of cutaneous T-cell lymphoma (CTCL)","volume":"8","author":"Alpdogan","year":"2019","journal-title":"Chinese Clin Oncol"},{"key":"2022012102313899400_onco13785-bib-0008","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/leu.2011.237","article-title":"Regulatory T cells and immunodeficiency in mycosis fungoides and S\u00e9zary syndrome","volume":"26","author":"Krejsgaard","year":"2012","journal-title":"Leukemia"},{"key":"2022012102313899400_onco13785-bib-0009","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3390\/cancers11111711","article-title":"STAT3 dysregulation in mature T and NK cell lymphomas","volume":"11","author":"Seffens","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2022012102313899400_onco13785-bib-0010","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/j.jid.2018.06.176","article-title":"An integrated data resource for genomic analysis of cutaneous T-cell lymphoma","volume":"138","author":"Chang","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2022012102313899400_onco13785-bib-0011","doi-asserted-by":"crossref","first-page":"75954","DOI":"10.18632\/oncotarget.12488","article-title":"Doxycycline is an NF-\u03baB inhibitor that induces apoptotic cell death in malignant T-cells","volume":"7","author":"Alexander-Savino","year":"2016","journal-title":"Oncotarget"},{"key":"2022012102313899400_onco13785-bib-0012","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1128\/AAC.47.11.3630-3633.2003","article-title":"Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines","volume":"47","author":"Krakauer","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2022012102313899400_onco13785-bib-0013","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/CCO.0000000000000048","article-title":"Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma","volume":"26","author":"Huen","year":"2014","journal-title":"Curr Opin Oncol"},{"key":"2022012102313899400_onco13785-bib-0014","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archderm.138.9.1137","article-title":"Treatment of stage IA cutaneous T-cell lymphoma with topical application of the immune response modifier imiquimod","volume":"138","author":"Suchin","year":"2002","journal-title":"Arch Dermatol"},{"key":"2022012102313899400_onco13785-bib-0015","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1182\/blood-2002-01-0231","article-title":"S\u00e9zary syndrome patients demonstrate a defect in dendritic cell populations: Effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines","volume":"100","author":"Wysocka","year":"2002","journal-title":"Blood"},{"key":"2022012102313899400_onco13785-bib-0016","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/eji.1830270526","article-title":"Effect of interleukin-10 on dendritic cell maturation and function","volume":"27","author":"De Smedt","year":"1997","journal-title":"Eur J Immunol"},{"key":"2022012102313899400_onco13785-bib-0017","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jnci\/dji207","article-title":"Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment","volume":"97","author":"Urosevic","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"2022012102313899400_onco13785-bib-0018","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/B:APPT.0000025805.55340.c3","article-title":"Immune modulation and apoptosis induction: Two sides of the antitumoral activity of imiquimod","volume":"9","author":"Sch\u00f6n","year":"2004","journal-title":"Apoptosis"},{"key":"2022012102313899400_onco13785-bib-0019","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2133.1974.tb12449.x","article-title":"Mycosis fungoides\u2014A disease of antigen persistence","volume":"91","author":"Tan","year":"1974","journal-title":"Br J Dermatol"},{"key":"2022012102313899400_onco13785-bib-0020","first-page":"591","article-title":"Exposure to chemicals, physical agents, and biologic agents in mycosis fungoides and the Sezary syndrome","volume":"63","author":"Fischmann","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"2022012102313899400_onco13785-bib-0021","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"2022012102313899400_onco13785-bib-0022","volume-title":"Veterans and Agent Orange: Update 11","author":"National Academies of Sciences, Engineering, and Medicine","year":"2018"},{"key":"2022012102313899400_onco13785-bib-0023","volume-title":"Compend Fed Med","author":"Boyle","year":"2014"},{"key":"2022012102313899400_onco13785-bib-0024","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/1346-8138.12202","article-title":"Clinicopathological features of mycosis fungoides in patients exposed to Agent Orange during the Vietnam War","volume":"40","author":"Jang","year":"2013","journal-title":"J Dermatol"},{"key":"2022012102313899400_onco13785-bib-0025","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1056\/NEJMra1805035","article-title":"Epigenetic therapies for cancer","volume":"383","author":"Bates","year":"2020","journal-title":"N Engl J Med"},{"key":"2022012102313899400_onco13785-bib-0026","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0006-2952(99)00310-X","article-title":"Role of the aromatic hydrocarbon receptor and (Ah) gene battery in the oxidative stress response, cell cycle control, and apoptosis","volume":"59","author":"Nebert","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"2022012102313899400_onco13785-bib-0027","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/jcb.20656","article-title":"Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis","volume":"96","author":"Marlowe","year":"2005","journal-title":"J Cell Biochem"},{"key":"2022012102313899400_onco13785-bib-0028","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2486\/indhealth.41.158","article-title":"Immunotoxicological effects of Agent Orange exposure to the Vietnam war Korean veterans","volume":"41","author":"Kim","year":"2003","journal-title":"Ind Health"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/onco.13785","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/onco.13785","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/26\/9\/727\/42247220\/oncolo_26_9_727.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/26\/9\/727\/42247220\/oncolo_26_9_727.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T21:33:20Z","timestamp":1642714400000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/26\/9\/727\/6512097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,14]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,5,14]]},"published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1002\/onco.13785","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,5,14]]}}}